They are a metabolic tool and like any tool, their outcome depends entirely on how you use them
Introduction : Elevated plasma levels of uric acid (UA) are considered an independent risk factor for hypertension, diabetes, cardiovascular disease, endothelial and vascular damage, obesity, and metabolic syndrome
Ongoing treatment paired with support like dose titration, side-effect management, dietary guidance, and regular follow-ups can help patients stay on therapy and sustain its benefits
This may partly reflect its popularity and widespread use, which increases the total number of adverse event reports
Further research is warranted using datasets that include weight, TSH, and HbA1c measurements (such as EHR data) to formally disentangle the mechanisms linking GLP-1RA initiation, weight loss, optimal levothyroxine dosing, and cardiovascular outcomes
Association between prescription trends and online search activities The study found significant associations between prescriptions and online search volumes for phentermine, liraglutide, semaglutide, and tirzepatide, with semaglutide and tirzepatide showing the highest associations